Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline
LCA-0321 is a LYTAC degrader designed to specifically bind and rapidly deplete anti-TSHR autoantibodies, the underlying cause of Graves’ disease and its extrathyroidal manifestations, including ...
Rolling Out20h
Why your food cravings signal silent health problem
Medical experts reveal how intense cravings for fried foods and sweets might indicate underlying health conditions you ...